BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6864694)

  • 21. Ulceration of striae distensae in a patient with systemic lupus erythematosus.
    Cordeiro RC; Moraes AM
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):390-2. PubMed ID: 18269620
    [No Abstract]   [Full Text] [Related]  

  • 22. Lupus erythematosus: systemic and cutaneous manifestations.
    Rothfield N; Sontheimer RD; Bernstein M
    Clin Dermatol; 2006; 24(5):348-62. PubMed ID: 16966017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus nephritis.
    Johns Hopkins Med J; 1982 Mar; 150(3):101-6. PubMed ID: 7062572
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic plasmapheresis in the combined therapy of systemic lupus erythematosus (a case report)].
    Kalinin NN; Pashinin AN; Alekberova ZS; Folomeev MIu; Kliukvina NG
    Ter Arkh; 1993; 65(7):85-6. PubMed ID: 8211790
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of systemic lupus erythematosus (I)].
    Font J; Cardellach F; Ingelmo M
    Med Clin (Barc); 1986 Apr; 86(14):604-9. PubMed ID: 3724270
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic lupus erythematosus XII: Cytotoxic therapy and pheresis.
    Stevens MB
    Md State Med J; 1984 Jul; 33(7):538-40. PubMed ID: 6381919
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasmapheresis: an adjunct therapy in severe progressive neuropsychiatric lupus.
    Gokhale YA; Bhide S; Rajadhyaksha S; Bichile LS; Hase NK
    J Assoc Physicians India; 2001 Oct; 49():986-9. PubMed ID: 11848331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
    Euler HH; Guillevin L
    Ann Med Interne (Paris); 1994; 145(5):296-302. PubMed ID: 7985935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasmapheresis therapy in severe lupus erythematosus D.N.A. serum antodies and erythrocyte sedimentation rate for therapy control (author's transl)].
    Meffert H; Böhm F; Apostoloff E; Kramm HJ
    Dermatol Monatsschr; 1980 May; 166(5):331-5. PubMed ID: 6968281
    [No Abstract]   [Full Text] [Related]  

  • 30. Short and longterm experience with plasmapheresis in connective tissue diseases.
    Dequeker J; Geusens P; Wielands L
    Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe cutaneous ulcerations in a black woman with systemic lupus erythematosus.
    Caproni M; Chiarugi A; Bernacchi E; Fabbri P
    Clin Exp Rheumatol; 1998; 16(4):508. PubMed ID: 9706440
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasmapheresis in systemic lupus erythematosus: facts and perspectives.
    Balow JE; Tsokos GC
    Int J Artif Organs; 1982 Sep; 5(5):286-9. PubMed ID: 6983501
    [No Abstract]   [Full Text] [Related]  

  • 33. Fulminant lupus pneumonitis with acute renal failure and RBC aplasia. Successful management with plasmapheresis and immunosuppression.
    Isbister JP; Ralston M; Hayes JM; Wright R
    Arch Intern Med; 1981 Jul; 141(8):1081-3. PubMed ID: 7247596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of skin disease in patients with lupus erythematosus.
    Callen JP
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):245-64. PubMed ID: 12041952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombotic thrombocytopenic purpura in a girl with systemic lupus erythematosus.
    Oen K; Petty RE; Schroeder ML; Briggs EJ; Bishop AJ
    J Rheumatol; 1980; 7(5):727-9. PubMed ID: 6892485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lupus erythematosus; current treatment methods].
    Nossent JC
    Ned Tijdschr Geneeskd; 1993 Mar; 137(11):558. PubMed ID: 8464532
    [No Abstract]   [Full Text] [Related]  

  • 38. [Plasmosorption in the treatment of cold urticaria and systemic lupus erythematosus (a preliminary report)].
    Molodenkov MN; Lopukhin IuM; Evseev NG; Shurkalin BK; Ageev SL
    Vestn Dermatol Venerol; 1979 Aug; (8):58-60. PubMed ID: 494747
    [No Abstract]   [Full Text] [Related]  

  • 39. Systemic lupus erythematosus complicated by acute pulmonary hemorrhage: recovery following plasmapheresis and cytotoxic therapy.
    Millman RP; Cohen TB; Levinson AI; Kelley MA; Sachs ML
    J Rheumatol; 1981; 8(6):1021-3. PubMed ID: 7328560
    [No Abstract]   [Full Text] [Related]  

  • 40. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.